ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products is medical classification list by Centers for Medicare and Medicaid Services (CMS).

ICD-10-PCS code range (3E0), contains ICD-10-PCS codes for Circulatory, Administration, Physiological Systems and Anatomical Regions, Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Subscribe to Codify and get the code details in a flash.

PCS Tables

3E0

3 Administration
E Physiological Systems and Anatomical Regions
0 Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Body System / Region Approach Substance Qualifier
Character 4 Character 5 Character 6 Character 7
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
J Other Hormone
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
K Other Diagnostic Substance
P Platelet Inhibitor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
R Antiarrhythmic
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
D Nitric Oxide
F Other Gas
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Y Hyperthermic
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
A Stem Cells, Embryonic
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
U Joints
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
V Bones
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas

December 31, 1969
Mobile crisis intervention services deliver fast appropriate care to individuals in crisis and help to avoid unnecessary costly ER visits and hospitalizations. In an effort to expand behavioral health... [ Read More ]
December 31, 1969
Weeks after finalizing payment rates and policy changes affecting Medicare services furnished in hospital outpatient and Ambulatory Surgical Center ASC settings for calendar year CY 2022 the Centers f... [ Read More ]
December 31, 1969
The updated format for AAPC 2022 certification exams was the topic of the December 22 AAPC Social Hour on Facebook Live. AAPC recently announced that exams will now consist of 100 questions that must ... [ Read More ]
December 31, 1969
New COVID19 vaccine status codes changes and corrections to the 2022 CPT code set Medicare Physician Fee Schedule MPFS payment changes and prior authorization code list changes thats whats on the age... [ Read More ]
December 31, 1969
Resolve to make your resolutions attainable by setting realistic goals. According to statista.com losing weight and saving more money were the most common New Years resolutions last year. Improving ea... [ Read More ]
Our Family Practice Clinic is doing telemed visits. We have had a few patient come in after their appointment for an In House Lab. The Telemed has the location as 02. The Lab has the office locatio... [ Read More ]
I read on AMA site of modifier 93 (used for telemedicine for audio use only) for 2022. CPT codes 99441, 42, 43 and 44 are codes that were implemented in 2020 for telemedicine audio use only. My questi... [ Read More ]
Can someone please give me some guidance on this modifier? I received a letter from Cigna stating that we would need to start appending this modifier to our claims for patient's seen by our NP. Our NP... [ Read More ]
I recently started coding several lab tests - 88334, 88335, 84165, 84166. Often on the results report there is no diagnosable condition or clinical history listed. I get things like: "Weak IGG ... [ Read More ]
I have questions about the proper billing for an ambulatory infusion center at our hospital. The infusion center wants to bill an e/m code for every visit. They usually use 99212. There is no physi... [ Read More ]
Hoping that I can get some guidance here. During two separate audits of telehealth visits performed during the pandemic, our auditors identified that providers are noting “no exam performed” in t... [ Read More ]
I work for an Infectious disease clinic. Dr. billed T84.50XA as the primary and only dx for an office visit (POS 11), and insurance denied for: Per cpt guidelines , this service is not appropriate in... [ Read More ]
Looking for any ideas on what the proper coding may be for this procedure: 1. Endoscopic Transoral Left-sided anterior maxillectomy approach to V2 and skullbase 2. Endoscopic V2 Foraminotomy with Ul... [ Read More ]
Is RPAV considered a branch or the distal extension of the RCA? DES was placed prox and mid RCA. C9600-RC. ( facility) intervention also states RPAV lesion DES placed. Is C9601-XU,RC correct? I... [ Read More ]
My doc is billing 20550 & 64450 together and I keep getting a CO-97 denial on 64450. It is not being billed for plantar fasciitis but instead a forearm nerve injury. I can't find a clear answer on... [ Read More ]